SYS ONLINE
SUPPLEMENT_SCHOLAR
evidence · mechanism · dose
Experimental/Reproductive / HPGResearch peptide

Gonadorelin

aka GnRH · LHRH

Synthetic native GnRH used to drive pulsatile pituitary LH/FSH release.

Educational explainer of a research peptide. Profiles in this section deliberately omit clinical-trial citations, dosing protocols, and purchase links. Not FDA-approved as a supplement; not a recommendation to use.

Overview

Gonadorelin is synthetic GnRH (gonadotropin-releasing hormone), identical to the hypothalamic decapeptide that drives pituitary LH and FSH release.

Source
  • Synthesized in research laboratories
Forms
  • Subcutaneous injection (pulsatile pump in some protocols)

Mechanism of action

Binds pituitary GnRH receptors to release LH and FSH; pulsatile dosing supports physiological response, continuous dosing desensitizes (the basis for medical castration).

Pathways
  • · GnRH receptor pulsatile signaling
  • · LH and FSH release
Receptors
  • · GnRH receptor
Hormones
  • · LH
  • · FSH
  • · Testosterone
  • · Estradiol

How it acts on the body

Gonadorelin produces a faithful native-GnRH signal, which makes it useful both for restoring HPG axis function (pulsatile delivery mimics the natural ~90-minute pulse) and for diagnostic stimulation testing.

Critically, continuous (non-pulsatile) GnRH signaling has the opposite effect: it desensitizes the pituitary receptors and shuts down LH/FSH output — which is how related agonists like leuprolide produce chemical castration. The same molecule can therefore be stimulating or suppressive depending on how it is delivered.

Hormonal & endocrine impact

How this peptide is reported to shift specific hormones and signaling molecules. Directionality reflects research literature and preclinical models, not clinical prescribing data.

Projected hormonal trajectory
Illustrative curves derived from reported direction of effect. Not measured patient data.

Curves are schematic shapes (sigmoid for increases/decreases, damped oscillation for modulation/stabilization) anchored to a 100% baseline. They communicate direction and tempo of change reported in research literature — not absolute hormone concentrations.

LH / FSHIncreases
Pulsatile dosing produces physiological gonadotropin pulses.
Testosterone / EstradiolIncreases
Downstream gonadal response with pulsatile protocols.
HPG axis sensitivityModulates
Continuous exposure desensitizes; pulses preserve sensitivity.

Effects on the body

Increases
LH/FSH with pulsatile use
Supports
Restoration of HPG axis function
Inhibits
HPG axis with continuous administration

Organ system effects

Endocrine

Direct pituitary activation or desensitization.

Reproductive

Downstream gonadal effects.

Reported effects

Drawn from preclinical research, anecdote, and small-scale clinical observation. No evidence grades are assigned — most peptides on this page lack rigorous human trials.

  • Mimics native GnRH pulses
  • Diagnostic and therapeutic uses in hypogonadism

Potential side effects

Common
  • · Injection-site reactions
  • · Headache
Rare
  • · Hot flashes
Serious
  • · Anaphylaxis (rare)
  • · Desensitization with wrong dosing pattern

Drug interactions

GnRH agonists or antagonists
Direct mechanism conflict.
severe

Pairing context

Often combined with
  • Pulsatile pump delivery
    Preserves pituitary responsiveness.
Avoid combining with
  • Hormone-sensitive malignancy
    Activates gonadal steroidogenesis.
Important. Research peptides described here are not FDA-approved supplements. Supplement Scholar does not endorse, recommend, or link to any source for purchase. Consult a qualified clinician before considering any peptide therapy.